Estimating lifetime medical costs from censored claims data
Author
Abstract
Suggested Citation
DOI: 10.1002/hec.3512
Download full text from publisher
References listed on IDEAS
- Anirban Basu & Willard G. Manning, 2010. "Estimating lifetime or episode‐of‐illness costs under censoring," Health Economics, John Wiley & Sons, Ltd., vol. 19(9), pages 1010-1028, September.
- Ruth Etzioni & Scott D. Ramsey & Kristin Berry & Martin Brown, 2001. "The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study," Health Economics, John Wiley & Sons, Ltd., vol. 10(3), pages 245-256, April.
- O'Hagan, Anthony & Stevens, John W., 2004. "On estimators of medical costs with censored data," Journal of Health Economics, Elsevier, vol. 23(3), pages 615-625, May.
- Mei-Chuan Hung & Hsin-Ming Lu & Likwang Chen & Ming-Shian Lin & Cheng-Ren Chen & Chong-Jen Yu & Jung-Der Wang, 2012. "Cost per QALY (Quality-Adjusted Life Year) and Lifetime Cost of Prolonged Mechanical Ventilation in Taiwan," PLOS ONE, Public Library of Science, vol. 7(9), pages 1-10, September.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Ash Bullement & Matthew D. Stevenson & Gianluca Baio & Gemma E. Shields & Nicholas R. Latimer, 2023. "A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment," Medical Decision Making, , vol. 43(5), pages 610-620, July.
- Szu-Chun Yang & Wu-Wei Lai & Tzu-I. Wu & Jing-Shiang Hwang & Jung-Der Wang & Fuhmei Wang, 2024. "Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancer," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(5), pages 775-785, July.
- Szu-Chun Yang & Wu-Wei Lai & Jason C Hsu & Wu-Chou Su & Jung-Der Wang, 2020. "Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan," PLOS ONE, Public Library of Science, vol. 15(4), pages 1-13, April.
- Enoch Yi-Tung Chen & Yuliya Leontyeva & Chia-Ni Lin & Jung-Der Wang & Mark S. Clements & Paul W. Dickman, 2024. "Comparing Survival Extrapolation within All-Cause and Relative Survival Frameworks by Standard Parametric Models and Flexible Parametric Spline Models Using the Swedish Cancer Registry," Medical Decision Making, , vol. 44(3), pages 269-282, April.
- Jing-Shiang Hwang & Tsuey-Hwa Hu, 2020. "Later-Life Exposure to Moderate PM 2.5 Air Pollution and Life Loss of Older Adults in Taiwan," IJERPH, MDPI, vol. 17(6), pages 1-12, March.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Lu Deng & Wendy Lou & Nicholas Mitsakakis, 2019. "Modeling right-censored medical cost data in regression and the effects of covariates," Statistical Methods & Applications, Springer;Società Italiana di Statistica, vol. 28(1), pages 143-155, March.
- Anirban Basu & Willard G. Manning, 2010. "Estimating lifetime or episode‐of‐illness costs under censoring," Health Economics, John Wiley & Sons, Ltd., vol. 19(9), pages 1010-1028, September.
- Maria Raikou & Alistair McGuire, 2012.
"Estimating Costs for Economic Evaluation,"
Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 43,
Edward Elgar Publishing.
- Maria Raikou & Alistair McGuire, 2006. "Estimating Costs for Economic Evaluation," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, chapter 40, Edward Elgar Publishing.
- Kontodimopoulos, Nick & Niakas, Dimitris, 2008. "An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy," Health Policy, Elsevier, vol. 86(1), pages 85-96, April.
- Y. T. Hwang & C. H. Huang & W. L. Yeh & Y. D. Shen, 2017. "The weighted general linear model for longitudinal medical cost data – an application in colorectal cancer," Journal of Applied Statistics, Taylor & Francis Journals, vol. 44(2), pages 288-307, January.
- Mauro Laudicella & Paolo Li Donni & Kim Rose Olsen & Dorte Gyrd‐Hansen, 2022.
"Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure,"
Health Economics, John Wiley & Sons, Ltd., vol. 31(6), pages 1184-1201, June.
- Laudicella, Mauro & Di Donni, Paolo & Rose Olsen, Kim & Gyrd-Hansen, Dorte, 2020. "Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure," DaCHE discussion papers 2020:4, University of Southern Denmark, Dache - Danish Centre for Health Economics.
- John Mullahy, 2015. "In Memoriam: Willard G. Manning, 1946‐2014," Health Economics, John Wiley & Sons, Ltd., vol. 24(3), pages 253-257, March.
- Liu, Lei & Conaway, Mark R. & Knaus, William A. & Bergin, James D., 2008. "A random effects four-part model, with application to correlated medical costs," Computational Statistics & Data Analysis, Elsevier, vol. 52(9), pages 4458-4473, May.
- Michelle Tew & Philip Clarke & Karin Thursky & Kim Dalziel, 2019. "Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients," PharmacoEconomics, Springer, vol. 37(7), pages 931-941, July.
- David Lairson & Rohan Parikh & Janice Cormier & Wenyaw Chan & Xianglin Du, 2014. "Cost–Utility Analysis of Chemotherapy Regimens in Elderly Patients with Stage III Colon Cancer," PharmacoEconomics, Springer, vol. 32(10), pages 1005-1013, October.
- David H. Howard & Florence K. Tangka & Laura C. Seeff & Lisa C. Richardson & Donatus U. Ekwueme, 2009. "The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer," Health Economics, John Wiley & Sons, Ltd., vol. 18(12), pages 1381-1393, December.
- Zhao, Xiaobing & Zhou, Xian, 2012. "Estimation of medical costs by copula models with dynamic change of health status," Insurance: Mathematics and Economics, Elsevier, vol. 51(2), pages 480-491.
- Laura Kimmey & Michael Anderson & Valerie Cheh & Evelyn Li & Catherine McLaughlin & Linda Barterian & Jay Crosson & Cara Stepanczuk & Lori Timmins & Jiaqi Li & Shannon Heitkamp & Christine Cheu & Tyle, "undated". "Evaluation of the Independence at Home Demonstration: An Examination of the First Four Years," Mathematica Policy Research Reports f92acd5d008b4cbc82f7e940e, Mathematica Policy Research.
- Liu, Chin-Jung & Kung, Pei-Tseng & Chu, Chia-Chen & Chou, Wen-Yu & Wang, Yueh-Hsin & Tsai, Wen-Chen, 2018. "Propensity score-matching analyses on the effectiveness of integrated prospective payment program for patients with prolonged mechanical ventilation," Health Policy, Elsevier, vol. 122(9), pages 970-976.
- Howard, David H., 2005. "Life expectancy and the value of early detection," Journal of Health Economics, Elsevier, vol. 24(5), pages 891-906, September.
- Basu A & Manning WG, 2009. "Estimating Lifetime or Episode-of-illness Costs," Health, Econometrics and Data Group (HEDG) Working Papers 09/12, HEDG, c/o Department of Economics, University of York.
- Bernadette Li & John Cairns & James Fotheringham & Rommel Ravanan, 2016. "Predicting hospital costs for patients receiving renal replacement therapy to inform an economic evaluation," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(6), pages 659-668, July.
- Manca, A & Austin, P. C, 2008. "Using propensity score methods to analyse individual patient-level cost-effectiveness data from observational studies," Health, Econometrics and Data Group (HEDG) Working Papers 08/20, HEDG, c/o Department of Economics, University of York.
- Mohamed El Alili & Johanna M. van Dongen & Jonas L. Esser & Martijn W. Heymans & Maurits W. van Tulder & Judith E. Bosmans, 2022. "A scoping review of statistical methods for trial‐based economic evaluations: The current state of play," Health Economics, John Wiley & Sons, Ltd., vol. 31(12), pages 2680-2699, December.
- Jan B. Oostenbrink & Maiwenn J. Al, 2005. "The analysis of incomplete cost data due to dropout," Health Economics, John Wiley & Sons, Ltd., vol. 14(8), pages 763-776, August.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:hlthec:v:26:y:2017:i:12:p:e332-e344. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www3.interscience.wiley.com/cgi-bin/jhome/5749 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.